chr3-8753079-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_000916.4(OXTR):c.1068C>A(p.Arg356Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000783 in 1,614,186 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00054 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00081 ( 26 hom. )
Consequence
OXTR
NM_000916.4 synonymous
NM_000916.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.59
Genes affected
OXTR (HGNC:8529): (oxytocin receptor) The protein encoded by this gene belongs to the G-protein coupled receptor family and acts as a receptor for oxytocin. Its activity is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. The oxytocin-oxytocin receptor system plays an important role in the uterus during parturition. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 3-8753079-G-T is Benign according to our data. Variant chr3-8753079-G-T is described in ClinVar as [Benign]. Clinvar id is 715951.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.59 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.000809 (1182/1461884) while in subpopulation EAS AF= 0.0286 (1135/39700). AF 95% confidence interval is 0.0272. There are 26 homozygotes in gnomad4_exome. There are 580 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 82 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OXTR | NM_000916.4 | c.1068C>A | p.Arg356Arg | synonymous_variant | 4/4 | ENST00000316793.8 | NP_000907.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OXTR | ENST00000316793.8 | c.1068C>A | p.Arg356Arg | synonymous_variant | 4/4 | 1 | NM_000916.4 | ENSP00000324270.2 | ||
CAV3 | ENST00000472766.1 | n.155+19089G>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000539 AC: 82AN: 152184Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
82
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00116 AC: 291AN: 251362Hom.: 3 AF XY: 0.00103 AC XY: 140AN XY: 135856
GnomAD3 exomes
AF:
AC:
291
AN:
251362
Hom.:
AF XY:
AC XY:
140
AN XY:
135856
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000809 AC: 1182AN: 1461884Hom.: 26 Cov.: 32 AF XY: 0.000798 AC XY: 580AN XY: 727242
GnomAD4 exome
AF:
AC:
1182
AN:
1461884
Hom.:
Cov.:
32
AF XY:
AC XY:
580
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000538 AC: 82AN: 152302Hom.: 1 Cov.: 32 AF XY: 0.000725 AC XY: 54AN XY: 74480
GnomAD4 genome
AF:
AC:
82
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
54
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
22
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 14, 2017 | - - |
OXTR-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at